Published in J Virol on October 01, 2005
Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog (2014) 1.69
Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J Virol (2005) 1.18
Identification of nonessential regions of the nsp2 replicase protein of porcine reproductive and respiratory syndrome virus strain VR-2332 for replication in cell culture. J Virol (2007) 1.10
A host dicer is required for defective viral RNA production and recombinant virus vector RNA instability for a positive sense RNA virus. Proc Natl Acad Sci U S A (2008) 1.08
Dynamics of coronavirus replication-transcription complexes. J Virol (2009) 1.07
Genome organization and reverse genetic analysis of a type I feline coronavirus. J Virol (2007) 0.96
Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines. Vaccine (2009) 0.94
Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range. J Virol (2006) 0.88
Soluble receptor-mediated targeting of mouse hepatitis coronavirus to the human epidermal growth factor receptor. J Virol (2005) 0.83
Murine coronaviruses encoding nsp2 at different genomic loci have altered replication, protein expression, and localization. J Virol (2008) 0.82
Molecular imaging of influenza and other emerging respiratory viral infections. J Infect Dis (2011) 0.80
ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells. J Virol (2015) 0.78
Infectious Bronchitis Virus as a Vector for the Expression of Heterologous Genes. PLoS One (2013) 0.78
Safe and Sensitive Antiviral Screening Platform Based on Recombinant Human Coronavirus OC43 Expressing the Luciferase Reporter Gene. Antimicrob Agents Chemother (2016) 0.75
The molecular biology of coronaviruses. Adv Virus Res (1997) 6.62
Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J Virol (1990) 4.19
Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc Natl Acad Sci U S A (1989) 3.65
Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol (2000) 3.46
Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology (1988) 2.83
A new model for coronavirus transcription. Adv Exp Med Biol (1998) 2.75
The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology (2002) 2.72
Sequence motifs involved in the regulation of discontinuous coronavirus subgenomic RNA synthesis. J Virol (2004) 2.30
A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol (1991) 2.30
Advances in the molecular biology of tombusviruses: gene expression, genome replication, and recombination. Prog Nucleic Acid Res Mol Biol (2004) 2.08
Direct measurement of the poliovirus RNA polymerase error frequency in vitro. J Virol (1988) 1.99
The primary structure of crossover regions of intertypic poliovirus recombinants: a model of recombination between RNA genomes. Virology (1986) 1.98
Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol (1999) 1.86
Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J Virol (1994) 1.85
Heterologous gene expression from transmissible gastroenteritis virus replicon particles. J Virol (2002) 1.85
Studies on the recombination between RNA genomes of poliovirus: the primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants. Virology (1987) 1.81
Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology (2001) 1.71
The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology (1995) 1.68
Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology (2001) 1.68
The RNA structures engaged in replication and transcription of the A59 strain of mouse hepatitis virus. J Gen Virol (2001) 1.66
Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol (2004) 1.62
Determination of the poliovirus RNA polymerase error frequency at eight sites in the viral genome. J Virol (1992) 1.61
Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome. J Virol (2002) 1.57
Murine coronavirus nonstructural protein ns2 is not essential for virus replication in transformed cells. J Virol (1990) 1.57
Switching species tropism: an effective way to manipulate the feline coronavirus genome. J Virol (2003) 1.54
Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis. J Virol (2005) 1.49
The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication. J Virol (1997) 1.48
Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system. J Neurovirol (2002) 1.45
Mutagenic analysis of the coronavirus intergenic consensus sequence. J Virol (1992) 1.45
Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence. Virology (2003) 1.45
Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J Virol (1993) 1.44
Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. J Virol (2001) 1.43
Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism. J Virol (2003) 1.42
Transcription regulatory sequences and mRNA expression levels in the coronavirus transmissible gastroenteritis virus. J Virol (2002) 1.38
Characterization of an essential RNA secondary structure in the 3' untranslated region of the murine coronavirus genome. J Virol (2000) 1.35
Coronavirus derived expression systems. J Biotechnol (2001) 1.32
Investigation of the control of coronavirus subgenomic mRNA transcription by using T7-generated negative-sense RNA transcripts. J Virol (1995) 1.26
Engineering the transmissible gastroenteritis virus genome as an expression vector inducing lactogenic immunity. J Virol (2003) 1.25
Coronaviruses as vectors: position dependence of foreign gene expression. J Virol (2003) 1.25
Insertion of a new transcriptional unit into the genome of mouse hepatitis virus. J Virol (1999) 1.19
Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. J Virol (2002) 1.15
Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression. J Virol (2002) 1.15
Coronavirus transcription mediated by sequences flanking the transcription consensus sequence. Virology (1996) 1.13
Expression of a foreign epitope by porcine reproductive and respiratory syndrome virus. Virology (2000) 1.09
Characterizations of coronavirus cis-acting RNA elements and the transcription step affecting its transcription efficiency. Virology (1998) 1.01
Recombinant equine arteritis virus as an expression vector. Virology (2001) 0.98
Evidence for new transcriptional units encoded at the 3' end of the mouse hepatitis virus genome. Virology (1993) 0.98
Genetic manipulation of equine arteritis virus using full-length cDNA clones: separation of overlapping genes and expression of a foreign epitope. Virology (2000) 0.94
Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59. Virology (2004) 0.94
Genetic variability: the key problem in the prevention and therapy of RNA-based virus infections. Med Res Rev (2003) 0.90
Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent. J Virol (2004) 0.89
Recombination between Sindbis virus RNAs. Arch Virol Suppl (1994) 0.87
Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure. J Virol (1997) 0.85
Construction of a mouse hepatitis virus recombinant expressing a foreign gene. Adv Exp Med Biol (1998) 0.84
Reverse genetic analysis of the transcription regulatory sequence of the coronavirus transmissible gastroenteritis virus. J Virol (2004) 0.83
Expression of transcriptional units using transmissible gastroenteritis coronavirus derived minigenomes and full-length cDNA clones. Adv Exp Med Biol (2001) 0.77
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol (2003) 3.71
The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology (2002) 2.72
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem (2005) 2.36
Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol (2012) 2.13
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A (2004) 1.89
Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray. J Clin Microbiol (2007) 1.89
Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog (2011) 1.66
Transformation proteins and DNA uptake localize to the cell poles in Bacillus subtilis. Cell (2005) 1.63
Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol (2004) 1.62
Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol (2004) 1.58
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol (2010) 1.55
Switching species tropism: an effective way to manipulate the feline coronavirus genome. J Virol (2003) 1.54
Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J Virol (2008) 1.47
Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J Virol (2005) 1.43
Mouse hepatitis coronavirus replication induces host translational shutoff and mRNA decay, with concomitant formation of stress granules and processing bodies. Cell Microbiol (2007) 1.38
Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus. J Virol (2013) 1.37
Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation. PLoS Pathog (2008) 1.36
Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J Gen Virol (2009) 1.36
The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity. Virology (2010) 1.33
Only two residues are responsible for the dramatic difference in receptor binding between swine and new pandemic H1 hemagglutinin. J Biol Chem (2010) 1.32
A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One (2010) 1.28
Molecular interactions in the assembly of coronaviruses. Adv Virus Res (2005) 1.27
Coronaviruses as vectors: position dependence of foreign gene expression. J Virol (2003) 1.25
Topology and membrane anchoring of the coronavirus replication complex: not all hydrophobic domains of nsp3 and nsp6 are membrane spanning. J Virol (2008) 1.23
Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J Virol (2005) 1.18
Virulence of Newcastle disease virus: what is known so far? Vet Res (2011) 1.18
Structural protein requirements in equine arteritis virus assembly. J Virol (2004) 1.16
Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. J Virol (2002) 1.15
Infectious bursal disease virus capsid protein VP3 interacts both with VP1, the RNA-dependent RNA polymerase, and with viral double-stranded RNA. J Virol (2002) 1.13
Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J Virol (2008) 1.12
Spike protein fusion peptide and feline coronavirus virulence. Emerg Infect Dis (2012) 1.09
Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step. J Virol (2010) 1.09
The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8. J Virol (2007) 1.07
Dynamics of coronavirus replication-transcription complexes. J Virol (2009) 1.07
Complete genome sequence and taxonomic position of anguillid herpesvirus 1. J Gen Virol (2009) 1.04
The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J Virol (2010) 1.04
Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry. J Virol (2007) 1.04
Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A (2009) 1.02
Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein. Virology (2005) 1.01
The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology (2003) 1.00
Sequence analysis of feline coronaviruses and the circulating virulent/avirulent theory. Emerg Infect Dis (2011) 0.99
Influenza A virus entry into cells lacking sialylated N-glycans. Proc Natl Acad Sci U S A (2012) 0.98
Visualizing coronavirus RNA synthesis in time by using click chemistry. J Virol (2012) 0.98
Rapid Emergence of Highly Pathogenic Avian Influenza Subtypes from a Subtype H5N1 Hemagglutinin Variant. Emerg Infect Dis (2015) 0.98
A mRNA PCR for the diagnosis of feline infectious peritonitis. J Virol Methods (2004) 0.97
Formation of disulfide-linked complexes between the three minor envelope glycoproteins (GP2b, GP3, and GP4) of equine arteritis virus. J Virol (2003) 0.97
A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles. PLoS One (2013) 0.96
Characterization of two new structural glycoproteins, GP(3) and GP(4), of equine arteritis virus. J Virol (2002) 0.95
Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions. J Virol (2013) 0.94
Mobility and interactions of coronavirus nonstructural protein 4. J Virol (2011) 0.93
Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin. J Virol (2012) 0.93
CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathog (2012) 0.92
An autophagy-independent role for LC3 in equine arteritis virus replication. Autophagy (2012) 0.92
Spike protein assembly into the coronavirion: exploring the limits of its sequence requirements. Virology (2005) 0.92
The coronavirus nucleocapsid protein is dynamically associated with the replication-transcription complexes. J Virol (2010) 0.92
Manipulation of the porcine epidemic diarrhea virus genome using targeted RNA recombination. PLoS One (2013) 0.91
Identification and localization of the structural proteins of anguillid herpesvirus 1. Vet Res (2011) 0.90
Quantitative proteomic identification of host factors involved in the Salmonella typhimurium infection cycle. Proteomics (2011) 0.90
Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications. Front Immunol (2013) 0.90
Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent. J Virol (2004) 0.89
The proteasome inhibitor Velcade enhances rather than reduces disease in mouse hepatitis coronavirus-infected mice. J Virol (2010) 0.88
Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range. J Virol (2006) 0.88
Anguillid herpesvirus 1 transcriptome. J Virol (2012) 0.88
Pathogenic characteristics of persistent feline enteric coronavirus infection in cats. Vet Res (2010) 0.87
Identification of host factors involved in coronavirus replication by quantitative proteomics analysis. Proteomics (2010) 0.87
Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell. J Virol (2014) 0.86
Non-invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo. Cell Microbiol (2009) 0.85
Intra- and intermolecular disulfide bonds of the GP2b glycoprotein of equine arteritis virus: relevance for virus assembly and infectivity. J Virol (2003) 0.85
Biogenesis and dynamics of the coronavirus replicative structures. Viruses (2012) 0.84
Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. Vaccine (2012) 0.83
Manipulation of the coronavirus genome using targeted RNA recombination with interspecies chimeric coronaviruses. Methods Mol Biol (2008) 0.83
Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection. Cell Microbiol (2006) 0.82
Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivo. BMC Genomics (2009) 0.82
Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain. J Virol (2003) 0.82
Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice. PLoS One (2012) 0.82
Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus. J Gen Virol (2002) 0.81
Two genetically closely related pigeon paramyxovirus type 1 (PPMV-1) variants with identical velogenic fusion protein cleavage sites but with strongly contrasting virulence. Vet Microbiol (2009) 0.80
Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis. Vet J (2012) 0.80
Improved microarray gene expression profiling of virus-infected cells after removal of viral RNA. BMC Genomics (2008) 0.79
Competition between influenza A virus genome segments. PLoS One (2012) 0.79
The intraleader AUG nucleotide sequence context is important for equine arteritis virus replication. Virus Genes (2006) 0.79
Homotypic interactions of the infectious bursal disease virus proteins VP3, pVP2, VP4, and VP5: mapping of the interacting domains. Virology (2003) 0.78
Genome-wide gene expression analysis of anguillid herpesvirus 1. BMC Genomics (2013) 0.77
Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma. J Virol (2009) 0.77
Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein. J Virol (2007) 0.77
Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses. Vet J (2009) 0.76
A field-proven yeast two-hybrid protocol used to identify coronavirus-host protein-protein interactions. Methods Mol Biol (2015) 0.75